StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 48.6%, against 39.1% the year before. The highest annual figure on record is 63.3% in fiscal 2022.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202548.6%+9.6
FY2024Dec 31, 202439.1%−20.1
FY2023Dec 31, 202359.2%−4.1
FY2022Dec 31, 202263.3%+4.9
FY2021Dec 31, 202158.4%+21.2
FY2020Dec 31, 202037.2%–

More CASI Pharmaceuticals figures

See a number that looks wrong?